Skip to Content

'
John F. DeGroot, M.D.

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Neuro-Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Director, Neuro-Oncology Fellowship Program, Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1998 University of Texas Medical Branch at Galveston, Galveston, TX, MD, Honors, Medicine
1992 Stanford University, Stanford, CA, BA, Human Biology

Postgraduate Training

7/2002-6/2004 Clinical Fellowship, Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
7/1999-6/2002 Clinical Residency, Neurology, Johns Hopkins University School of Medicine, Baltimore, MD
7/1998-6/1999 Clinical Internship, Neurology, Johns Hopkins Bayview Medical Center, Baltimore, MD

Board Certifications

5/2003 American Board of Psychiatry and Neurology

Experience/Service

Academic Appointments

Assistant Professor, Department of Neuro-Oncology, Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 7/2004-present

Selected Publications

Peer-Reviewed Original Research Articles
1. Gilbert MR, Gonzalez J, Hunter K, Hess K, Giglio P, Chang E, Puduvalli V, Groves MD, Colman H, Conrad C, LEvin V, Woo S, Mahajan A, de Groot J, Yung WKA. A Phase I Factorial Design Study of Dose-Dense Temozolomide Alone and in Combination with Thalidomide, Isotretinoin, and/or Celecoib as Postchemoradiation Adjuvant Therapy for Newly Diagnosed Glioblastoma. Neuro-Oncology 12(11). e-Pub 8/2010.
2. Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, Degroot J, Wick W, Gilbert MR, Lassman AB, Tsien C, Mikkelsen T, Wong ET, Chamberlain MC, Stupp R, Lamborn KR, Vogelbaum MA, van den Bent MJ, Chang SM. Updated response assessment criteria for high-grade gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group. J Clin Oncol 28(11):1963-72, 4/2010. e-Pub 3/2010. PMID: 20231676.
3. Ahluwalia MS, de Groot J, Liu W, Gladson CL. Targeting SRC in glioblastoma tumors and brain metastases: Rationale and preclinical studies. Cancer Letters 298(2):139-49, 2010. PMID: 20947248.
4. Lucio-Eterovic AK, Piao Y, de Groot JF. Mediators of Glioblastoma Resistance and Invasion during Antivascular Endothelial Growth Factor Therapy. Clin Cancer Res 15(14):4589-99, 7/2009. PMID: 19567589.
5. de Groot, Piao Y, Lu L. AMPA receptors promote perivascular glioma invasion via (beta) 1 integrin-dependent adhesion to the extracellular matrix. Neuro-Oncology 11(3):260-73, 6/2009. PMID: 18957620.
6. Milano V, Piao Y, Lafortune T, de Groot J. Desatinib-induced autophagy is enhaced in combination with temozolomide in glioma. Molecular Cancer Therapy 8(2):394-406, 2/2009. PMID: 19190119.
7. Gonzales J, de Groot J. Combination therapy for malignant glioma based on PTEN status. Expert Rev Anticancer Therapy 8(11):1767-1779, 11/2008. PMID: 18983237.
8. de Groot JF, Gilbert MR, Aldape K, Hess KR, Hanna TA, Ictech S, Groves MD, Conrad C, Colman H, Puduvalli VK, Levin V, Yung WK. Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma. J Neuro-Oncology 90(1):89-97, 10/2008. PMID: 18581057.
9. de Groot, WKA Yung. Bevacizumab and Irinotecan in the Treatment of Recurrent Malignant Gliomas. Cancer J 14(5):279-285, Sep-Oct, 2008. PMID: 18836331.
10. Gomez-Manzano C, Holash J, Fueyo J, Xu Jing, Conrad, CA, Aldape KD, DeGroot JF, Bekele N, Yung WKA. VEGF Trap induces antiglioma effect at different stages of disease. Neuro-Oncology 10(6):940-945, 2008. PMID: 18708344.
11. de Groot JF, Liu TJ, Fuller G, Yung WK. The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo. Cancer Res 65(5):1934-40, 2005. PMID: 15753393.

Book Chapters
1. deGroot JF, Yung, WK. Small Molecule Based Therapies. In Neuro-Oncology. In: The Essentials 2nd. Edition, 2nd. Ed(s) Bernstein & M. Berger. Thieme Publishers: New York, NY, 234-241, 2008.

Grant & Contract Support

Title: Targeting the JAK2/STAT-3 Pathway in Glioma to Overcome Resistance to Antiangiogenic Therapy
Funding Source: NIH/NCI
Role: Investigator
Duration: 9/1/2011 - 8/31/2012
 
Title: Preclinical Validation of Targeting the JAK/STAT Pathway in Glioma with AZD1480
Funding Source: AstraZeneca
Role: Investigator
Duration: 9/1/2011 - 8/1/2012
 
Title: Modulation of Resistance to Antiangiogenic Therapy: A Clinical Trial with Correlative Studies
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 7/16/2010 - 6/30/2012
 
Title: Preclinical Validation of Targeting Macrophage CSF-1R in Glioblastoma
Funding Source: AstraZeneca Research Collaboration Alliance
Role: Principal Investigator
Duration: 9/2009 - 10/31/2011
 
Title: Predictors of Glioblastoma Response to VEGF Trap
Funding Source: American Society of Clinical Oncology (ASCO)
Role: Principal Investigator
Duration: 7/1/2008 - 6/30/2011
 
Title: SPORE in Brain Cancer
Funding Source: NIH/NCI
Role: Co-Investigator
Duration: 7/1/2008 - 6/30/2010
 
Title: The Role of AMPA Receptors in Glioma Proliferation and Invasion
Funding Source: UTMDACC Institutional Research Grant-IRG
Role: Principal Investigator
Duration: 2/1/2008 - 1/31/2010
 
Title: The effect of CT-322 on glioma biology and growth in an in vivo glioma stem cell model
Funding Source: Adnexus
Role: Principal Investigator
Duration: 1/2008 - 1/31/2011
 
Title: Correlative Markers of Glioblastoma Response to VEGF Trap
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 6/2007 - 5/31/2010
 
Title: Deciphering Synergistic Combinatorial Targets in Glioma
Funding Source: NIH/NCI/NINDS
Role: Co-Investigator
Principal Investigator: W.K. Alfred Yung
Duration: 9/2006 - 6/30/2012
 
Title: Glutamate excitotoxicity, cystine and glioma growth
Funding Source: American Brain Tumor Association (ABTA) - Basic Research Fellowship
Role: Investigator
Duration: 7/3/2003 - 6/5/2005
 
Title: Multiscale Brain Cancer Modeling
Funding Source: NIH/NCI
Role: Co-Investigator
Principal Investigator: Deisboeck, Thomas and Cristini, Vittorio

Last updated: 12/12/2011